Cambridge Cognition Holdings (GB:COG) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Cambridge Cognition Holdings reports a positive outlook for 2025, with expected revenue growth fueled by an expanding order book and sales pipeline. The company anticipates reaching a revenue of at least £10 million for 2024, marking a near break-even adjusted EBITDA, while projecting significant revenue uplift and sustainable profitability in the coming year. Strategic acquisitions and increased repeat orders from top-tier pharmaceutical clients are key drivers of this growth.
For further insights into GB:COG stock, check out TipRanks’ Stock Analysis page.
